Get the Stockscreener App
0.99
0.90%
-0.009
Biofrontera Inc stock is traded at $0.99, with a volume of 80,490.
It is down -0.90% in the last 24 hours and up +34.33% over the past month.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
See More
Previous Close:
$0.999
Open:
$0.99
24h Volume:
80,490
Relative Volume:
0.35
Market Cap:
$11.54M
Revenue:
$39.19M
Net Income/Loss:
$-16.59M
P/E Ratio:
-0.4537
EPS:
-2.182
Net Cash Flow:
$-9.39M
1W Performance:
+18.56%
1M Performance:
+34.33%
6M Performance:
+9.88%
1Y Performance:
-2.94%
1-Day Range:
$0.9402
$1.00
1-Week Range:
$0.80
$1.00
52-Week Range:
$0.536
$1.2399
Biofrontera Inc Stock (BFRI) Company Profile
Name
Biofrontera Inc
Sector
Phone
781-245-1325
Address
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
0.9908 | 11.64M | 39.19M | -16.59M | -9.39M | -2.182 |
|
ZTS
Zoetis Inc
|
123.90 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.97 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.64 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
470.22 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Biofrontera Inc Stock (BFRI) Latest News
Merger Talk: Does Biofrontera Inc Equity Warrant stock reflect fundamentals2025 Bull vs Bear & Long-Term Safe Investment Ideas - baoquankhu1.vn
Can Biofrontera Inc. Equity Warrant stock maintain growth trajectoryJuly 2025 Closing Moves & Technical Buy Zone Confirmations - bollywoodhelpline.com
Aug Setups: Is Biofrontera Inc forming a breakout patternQuarterly Investment Review & AI Driven Stock Reports - baoquankhu1.vn
Gains Recap: Is Biofrontera Incs ROE strong enough2025 Market Overview & Expert Curated Trade Setups - baoquankhu1.vn
Biofrontera reports record quarterly revenue in Q4 2025 By Investing.com - Investing.com Nigeria
Published on: 2026-01-14 07:20:22 - Bộ Nội Vụ
Pharma News: Can Biofrontera Inc Equity Warrant stock rebound after recent weakness2025 Trade Ideas & Fast Entry Momentum Alerts - Bộ Nội Vụ
Biofrontera reports preliminary Q4 revenue $17M-$17.5M - TipRanks
Biofrontera reports record quarterly revenue in Q4 2025 - Investing.com
Record $17M quarter for Biofrontera as Ameluz PDT sales climb higher - Stock Titan
How Biofrontera Inc. Equity Warrant stock benefits from tech adoptionQuarterly Growth Report & Fast Exit and Entry Strategy Plans - ulpravda.ru
Can Biofrontera Inc. Equity Warrant stock deliver strong Q4 earningsWeekly Profit Summary & Community Consensus Trade Signals - Улправда
What Wall Street predicts for Biofrontera Inc. stock priceQuarterly Market Summary & Low Drawdown Investment Ideas - ulpravda.ru
Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones - Sahm
Will Biofrontera Inc. stock outperform Nasdaq indexWeekly Gains Summary & Smart Swing Trading Alerts - Улправда
Can Biofrontera Inc. Equity Warrant stock outperform in 2025 bull marketPortfolio Performance Report & Fast Gain Stock Trading Tips - Улправда
Will Biofrontera Inc. Equity Warrant stock benefit from infrastructure spendingJuly 2025 Selloffs & Weekly Market Pulse Updates - Улправда
Is Biofrontera Inc. Equity Warrant stock cheap at current valuationTrade Volume Summary & Daily Oversold Bounce Ideas - Улправда
Is Biofrontera Inc. Equity Warrant stock a safe haven assetJuly 2025 Trends & Weekly Watchlist for Consistent Profits - Улправда
Biofrontera reaches database lock milestone for skin treatment studies By Investing.com - Investing.com Australia
Will Biofrontera Inc. (AI10) stock outperform value peersMarket Trend Report & AI Enhanced Trade Execution Alerts - Улправда
Why Biofrontera Inc. (AI10) stock remains stableTake Profit & Accurate Entry/Exit Alerts - Улправда
Is Biofrontera Inc. Equity Warrant stock affected by interest rate hikesInflation Watch & High Conviction Buy Zone Alerts - Улправда
Biofrontera reaches database lock milestone for skin treatment studies - Investing.com
Biofrontera announces data base locks for two clinical studies - TipRanks
Biofrontera completes transfer of Ameluz, RhodoLED FDA approval - MSN
Biofrontera Receives Nasdaq Notice on Bid Price Noncompliance - TipRanks
Biofrontera Received Notice of Noncompliance - TradingView — Track All Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Sahm
Guidance Update: Can Biofrontera Inc Equity Warrant stock maintain growth trajectoryWeekly Earnings Recap & Growth Oriented Trading Recommendations - moha.gov.vn
Aug Summary: How resilient is Biofrontera Inc Equity Warrant stock in market downturnsAnalyst Upgrade & Free Accurate Trade Setup Notifications - moha.gov.vn
Retail Trends: Will Biofrontera Inc. stock split again soonJuly 2025 Summary & Weekly Top Gainers Alerts - Улправда
Is Biofrontera Inc. stock a top momentum playMarket Risk Report & Expert Verified Movement Alerts - Улправда
Will Biofrontera Inc. stock split again soonMarket Activity Report & Accurate Trade Setup Notifications - Улправда
How interest rate cuts could boost Biofrontera Inc. Equity Warrant stockGlobal Markets & AI Driven Stock Reports - Улправда
Will Biofrontera Inc. stock reach all time highs in 2025Profit Target & Long Hold Capital Preservation Plans - Улправда
Why Biofrontera Inc. stock remains resilientInflation Watch & Verified Swing Trading Watchlists - Улправда
Biofrontera completes transfer of FDA approvals for Ameluz and RhodoLED By Investing.com - Investing.com South Africa
How Biofrontera Inc. stock reacts to global recession fearsGold Moves & Expert Curated Trade Setups - Улправда
Biofrontera completes transfer of FDA approvals for Ameluz and RhodoLED - Investing.com
Biofrontera completes transfer of Ameluz® and Rhodoled® FDA approval - marketscreener.com
Biofrontera Inc. Completes Transfer of Ameluz® and RhodoLED® FDA approval and Associated Intellectual Property Portfolio - The Manila Times
Biofrontera Inc. Completes Transfer of Ameluz® and - GlobeNewswire
Book value per share of Biofrontera Inc. Warrant 2021-27.10.26 on Biofrontera – NASDAQ:BFRIW - TradingView — Track All Markets
Biofrontera Inc Stock (BFRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):